NO774225L - PROCEDURE FOR THE PREPARATION OF 1-AZIRIDINE-CARBOXYLIC ACID RESIDUES - Google Patents

PROCEDURE FOR THE PREPARATION OF 1-AZIRIDINE-CARBOXYLIC ACID RESIDUES

Info

Publication number
NO774225L
NO774225L NO774225A NO774225A NO774225L NO 774225 L NO774225 L NO 774225L NO 774225 A NO774225 A NO 774225A NO 774225 A NO774225 A NO 774225A NO 774225 L NO774225 L NO 774225L
Authority
NO
Norway
Prior art keywords
aziridine
ester
general formula
carboxylic acid
cyano
Prior art date
Application number
NO774225A
Other languages
Norwegian (no)
Inventor
Elmar Bosies
Ruth Heerdt
Rudi Gall
Uwe Bicker
Anna Elisabeth Ziegler
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762656323 external-priority patent/DE2656323A1/en
Priority claimed from DE19772740248 external-priority patent/DE2740248A1/en
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO774225L publication Critical patent/NO774225L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/16Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
    • C07D203/20Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carbonic acid, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

Fremgangsmåte ved fremstilling'av 1-aziridin-carboxylsyreester-derivater Process for the production of 1-aziridine carboxylic acid ester derivatives

Foreliggende oppfinnelse angår nye fremgangsmåter ved fremstilling av 1-aziridin-carboxylsyreester-derivater. The present invention relates to new methods for the production of 1-aziridine carboxylic acid ester derivatives.

I Tetrahedron Letters 1964, 2^97, beskriver W. Lwowski et al.. 2-cyan-l-aziridin-carboxylsyreethylesteren såvel som en fremgangsmåte for fremstilling av denne, men der gies ingen henvisning til en farmakologisk virkning. I rammen av arbeidene over 2-cyan-l-aziridin-carboxamid, et immunstimulerende terapeutikum ved bak-terie- og virus-infeksjoner (se tysk patent ansøkning P 25 28 460.0), har det nu vist seg at 2-cyan-1-aziridin-carboxylsyreethylest er er et egnet utgangsmateriale for fremstilling av dette terapeutikum. In Tetrahedron Letters 1964, 2^97, W. Lwowski et al. describe the 2-cyano-1-aziridine carboxylic acid ethyl ester as well as a method for its preparation, but no reference was made to a pharmacological effect. In the framework of the work on 2-cyan-l-aziridine-carboxamide, an immunostimulating therapeutic for bacterial and viral infections (see German patent application P 25 28 460.0), it has now been shown that 2-cyan-1- Aziridine carboxylic acid ethyl ester is a suitable starting material for the production of this therapeutic.

Det har overraskende vist seg at 2-cyan-1-aziridin-carboxylsyreethylesteren har en utpreget immunstimulerende virkning. Man står derfor overfor den oppgave å utvikle denne forbindelsestype videre, og å søke efter forbedrede fremgangsmåter for fremstilling av de kjente og nye forbindelser. It has surprisingly been shown that the 2-cyano-1-aziridine carboxylic acid ethyl ester has a distinct immunostimulating effect. One is therefore faced with the task of developing this type of compound further, and of searching for improved methods for the production of the known and new compounds.

Gjenstand for foreliggende oppfinnelse er nu nye fremgangsmåter ved fremstilling av forbindelsene med den generelle formel: The subject of the present invention is now new methods for the production of the compounds with the general formula:

hvor where

X er en nitril-, en carbamoyl- eller en alkoxycarbonylgruppe,X is a nitrile, a carbamoyl or an alkoxycarbonyl group,

R er en rettkjedet eller forgrenet, mettet eller umettet alkyl-gruppe, som eventuelt kan være substituert med halogen, alkoxy , amino, carbamoyloxy, cycloalkyl, hydroxy eller imido eller en heterocyclisk gruppe, eller R kan være cycloalkyl, aryl, aralkyl, aryloxyalkyl eller arylthioalkyl , idet arylgruppen eventuelt kan være substituert med halogen, alkyl, alkoxy, hydroxy, amino, nitro, cyano, acyl, carbalkoxy, thioalkyl, alkylsulfonyl, fenyl eller trif"luormethyl , R is a straight-chain or branched, saturated or unsaturated alkyl group, which may optionally be substituted with halogen, alkoxy, amino, carbamoyloxy, cycloalkyl, hydroxy or imido or a heterocyclic group, or R may be cycloalkyl, aryl, aralkyl, aryloxyalkyl or arylthioalkyl, where the aryl group can optionally be substituted with halogen, alkyl, alkoxy, hydroxy, amino, nitro, cyano, acyl, carbaloxy, thioalkyl, alkylsulfonyl, phenyl or trifluoromethyl,

såvel som anvendelsen av disse forbindelser ved fremstilling av legemidler med immunstimulerende virkning. as well as the use of these compounds in the preparation of pharmaceuticals with an immunostimulating effect.

Med alkyl menes i alle tilfelle en rettkjedet eller forgrenet kjede med 1-5 carbonatomer. Fortrinnsvis anvendes methyl-, ethyl-, isobutyl-, sek-butyl-, t-butyl- og n-pentylgruppen. Alkyl-kjedene kan eventuelt være substituert med halogen, som fluor, By alkyl is meant in all cases a straight-chain or branched chain with 1-5 carbon atoms. The methyl, ethyl, isobutyl, sec-butyl, t-butyl and n-pentyl groups are preferably used. The alkyl chains may optionally be substituted with halogen, such as fluorine,

klor og brom, eller en amino- eller hydroxygruppe. Som ytter-ligere substituenter finner carbamoyloxygruppen, fortrinnsvis 2-cyan-l-aziridin-carbonyloxygruppen, en imidogruppe, som f.eks. fthalimidogruppen, en heterocyclisk gruppe, særlig 2-tetrahydro-furyl- hhv. 2-tetrahydrothienylgruppen, alkoxy- eller cycloalkyl-gruppene anvendelse. Med alkoxy under substituentene X og R menes i alle tilfelle en gruppe med 1-5 carbonatomer, fortrinnsvis methoxy, ethoxy og isopropoxy. Med cycloalkyl forståes grupper med 3-10 carbonatomer, særlig cyclopropyl , cyclopentyl, cyclo-hexyl såvel som broinneholdende cycloalkylgrupper som f.eks. bor-nylgruppen. Som umettede alkylgrupper menes fremfor alt allyl- chlorine and bromine, or an amino or hydroxy group. As further substituents, the carbamoyloxy group, preferably the 2-cyan-1-aziridine carbonyloxy group, an imido group, such as e.g. the phthalimido group, a heterocyclic group, especially 2-tetrahydro-furyl or The 2-tetrahydrothienyl group, the alkoxy or cycloalkyl groups use. Alkoxy under the substituents X and R in all cases means a group with 1-5 carbon atoms, preferably methoxy, ethoxy and isopropoxy. Cycloalkyl means groups with 3-10 carbon atoms, especially cyclopropyl, cyclopentyl, cyclohexyl as well as bridge-containing cycloalkyl groups such as e.g. boron-nyl group. Unsaturated alkyl groups are above all allyl-

og crotylgruppen.and the crotyl group.

Som arylgruppe anvendes først og fremst aromater med 6 -As an aryl group, aromatics with 6 -

10 carbonatomer, som fenyl og nafthyl.10 carbon atoms, such as phenyl and naphthyl.

Aralkyl betegner fortrinnsvis benzyl og fenethyl, mens aryloxyalkyl betegner fortrinnsvis 2-fenoxyethy1, og arylthioalky1 betegner fortrinnsvis 2-f enylthioethyl . Aralkyl preferably denotes benzyl and phenethyl, while aryloxyalkyl preferably denotes 2-phenoxyethyl, and arylthioalkyl preferably denotes 2-phenylthioethyl.

Som thioalkyl anvendes først og fremst methylthio, og alkylsulfonyl er fortrinnsvis methylsulfonyl. Ved acylgruppen dreier det seg fortrinnsvis om formyl- og acetylgruppene. Med halogen menes fluor, klor og brom. Arylgruppen kan i alle tilfelle være substituert én eller flere ganger med de oppførte substituenter. As thioalkyl, methylthio is primarily used, and alkylsulfonyl is preferably methylsulfonyl. The acyl group is preferably the formyl and acetyl groups. Halogen means fluorine, chlorine and bromine. The aryl group can in all cases be substituted one or more times with the listed substituents.

Oppfinnelsens, gjenstand er dessuten samtlige st er eoisomere former av en forbindelse med den generelle formel I, som fåes på grunn av de asymmetriske carbonatomer. The object of the invention is also all isomeric forms of a compound of the general formula I, which are obtained due to the asymmetric carbon atoms.

Gjenstand for oppfinnelsen er videre de nye forbindelser med den generelle formel: The subject matter of the invention is further the new compounds with the general formula:

hvor where

X er en nit ril-, carbamoyl- eller alkoxycarbonylgruppe,X is a nitrile, carbamoyl or alkoxycarbonyl group,

R' er en rettkjedet eller forgrenet, mettet eller umettet alkyl-gruppe som eventuelt kan være substituert med halogen, alkoxy, R' is a straight-chain or branched, saturated or unsaturated alkyl group which may optionally be substituted with halogen, alkoxy,

amino, carbamoyloxy, cycloalkyl, hydroxy eller imido eller en heterocyclisk gruppe, eller R' kan være en cycloalkyl, aryl, amino, carbamoyloxy, cycloalkyl, hydroxy or imido or a heterocyclic group, or R' can be a cycloalkyl, aryl,

aralkyl, aryloxyalkyl eller arylthioalkyl, idet arylgruppen eventuelt kan være substituert med halogen, alkyl, alkoxy, hydroxy, amino, nitro, cyano, acyl, carbalkoxy, thioalkyl, alkylsulfonyl, fenyl eller trifluormethyl , aralkyl, aryloxyalkyl or arylthioalkyl, whereby the aryl group may optionally be substituted with halogen, alkyl, alkoxy, hydroxy, amino, nitro, cyano, acyl, carbaloxy, thioalkyl, alkylsulfonyl, phenyl or trifluoromethyl,

idet når X er en nit rilgruppe, kan R<*>ikke være ethyl .in that when X is a nitrile group, R<*> cannot be ethyl .

Som allerede nevnt, har forbindelsene med den generelleAs already mentioned, the connections with the general have

formel I overraskende en utpreget immunstimulerende virkning. Dessuten er de, når X er en nitrilgruppe, verdifulle utgangsmaterialer for fremstilling av 2-cyan-l-aziridin-carboxamid. Til dette omsettes forbindelser med den generelle formel I hvor X er en nitrilgruppe, med ammoniakk under dannelse av 2-cyan-1-aziridin-carboxam id. formula I surprisingly has a distinct immunostimulating effect. Moreover, when X is a nitrile group, they are valuable starting materials for the preparation of 2-cyano-1-aziridine carboxamide. For this, compounds of the general formula I where X is a nitrile group are reacted with ammonia to form 2-cyan-1-aziridine-carboxamide.

Forbindelsene med den generelle formel I kan fremstilles vedThe compounds of the general formula I can be prepared by

i og for seg kjente fremgangsmåter, fortrinnsvis ved atmethods known in and of themselves, preferably in that

a) et aziridinderivat med den generelle formel:a) an aziridine derivative of the general formula:

hvor where

X er som ovenfor angitt, omsettes med en halogenmaursyreester med den generelle formel: X is, as stated above, reacted with a halogen formic acid ester of the general formula:

hvor R er som ovenfor angitt, og Hal er klor eller brom, eller b) en forbindelse med den generelle formel: where R is as indicated above, and Hal is chlorine or bromine, or b) a compound of the general formula:

hvor X, R og Hal er som ovenfor angitt, behandles med halogen-avspaltende reagenser, eller c) en forbindelse.med den generelle formel: where X, R and Hal are as indicated above, treated with halogen-releasing reagents, or c) a compound of the general formula:

hvor X og R er som ovenfor angitt, ved katalytisk eller fotokjemisk where X and R are as above, by catalytic or photochemical

nitrogénavspaltning overføres til en forbindelse med den generelle formel I, og at derpå eventuelt forbindelser med den generelle formel I overføres til andre forbindelser med den generelle nitrogen removal is transferred to a compound of the general formula I, and that subsequently compounds of the general formula I are subsequently transferred to other compounds of the general formula

formel I.formula I.

Den efterfølgende overføring av forbindelser med den generelle formel I til andre forbindelser med den generelle formel I kan eventuelt skje ved overføring av substituenten X. He.rved kan f.eks. forbindelser hvor X er alkoxycarbonyl, ved omsetning med ammoniakk overføres til forbindelser hvor X er carbamoyl, idet disse igjen med dehydratiseringsmidler kan overføres til forbindelser hvor X er nitril. The subsequent transfer of compounds with the general formula I to other compounds with the general formula I can optionally take place by transferring the substituent X. Here, e.g. compounds where X is alkoxycarbonyl, by reaction with ammonia are transferred to compounds where X is carbamoyl, as these can again be transferred with dehydrating agents to compounds where X is nitrile.

Forbindelser med den generelle formel I hvor X er alkoxycarbonyl og carbamoyl, kan derfor også anvendes som utgangsmaterialer ved fremstilling av forbindelsene med den generelle formel I hvor x er nitril, idet særlig 2-carbamoyl-1-aziridin-carboxylsyre-estere med den generelle formel i kommer i betraktning. Compounds of the general formula I where X is alkoxycarbonyl and carbamoyl can therefore also be used as starting materials in the preparation of the compounds of the general formula I where x is nitrile, particularly 2-carbamoyl-1-aziridine carboxylic acid esters of the general formula in comes into consideration.

Overføringen av ester-gruppen til amid-gruppen lar seg best utføre med gassformig ammoniakk i et organisk oppløsningsmiddel, fortrinnsvis .i methanol eller et ha noi.' Der anvendes fortrinnsvis ekvimolare mengder ammoniakk, og reaksjonen får forløpe ved fra 0°C til +5°C. Det ønskede amid isoleres fra reaksjonsblandingen'f.eks. ved søylekromatografi . The transfer of the ester group to the amide group can best be carried out with gaseous ammonia in an organic solvent, preferably in methanol or ethanol. Equimolar amounts of ammonia are preferably used, and the reaction is allowed to proceed at from 0°C to +5°C. The desired amide is isolated from the reaction mixture, e.g. by column chromatography.

Ved overføringen av carbamoylgruppen til nit rilgruppen anvendes kjente dehydratiseringsmidler, idet der fremfor alt anvendes blandingen av trifenylfosfin, carbontetraklorid og triethylamin. Som oppløsningsmiddel anvendes vanligvis halogenerte hydrocarboner, f.eks. methylenklorid eller kloroform. Det ønskede nitril isoleres som regel fra reaksjonsblandingen ved destillasjon. In the transfer of the carbamoyl group to the nitrile group, known dehydrating agents are used, in which above all the mixture of triphenylphosphine, carbon tetrachloride and triethylamine is used. Halogenated hydrocarbons are usually used as solvents, e.g. methylene chloride or chloroform. The desired nitrile is usually isolated from the reaction mixture by distillation.

På den annen side kan f.eks. også substituentene R og R'. overføres til hverandre ved generelle fremgangsmåter for omestring, idet i alminnelighet en liten tilsetning av en basisk forbindelse f.eks. et alkali- eller jordalkalimetallhydroxyd eller et alkali-alkoholat er nødvendig. On the other hand, e.g. also the substituents R and R'. are transferred to each other by general methods for transesterification, as generally a small addition of a basic compound, e.g. an alkali or alkaline earth metal hydroxide or an alkali alcoholate is required.

Dessuten kan de nye forbindelser med den generelle formel I' fremstilles ved omsetning av nitrener med den generelle formel: hvor R' er som ovenfor angitt, med forbindelser.med den generelle formel: Moreover, the new compounds of the general formula I' can be prepared by reacting nitrenes of the general formula: where R' is as indicated above, with compounds of the general formula:

hvor X er som ovenfor angitt. where X is as indicated above.

Nitrener med den generelle formel VI, som kan fremstilles intermediært ved fotolyse av azidomaursyreestere eller ved u-eliminering ved hjelp av baser som triethylamin fra N-p-nitro-benzensulfonyloxyurethaner, reagerer uten videre med de anvendte acrylsyrederivater til de ønskede aziridiner med den generelle formel i<>>(f.eks. Tetrahedron Letters, 1964, 2497; J. Am. chem. soc. 87, 3630 [1965]) . Nitrenes of the general formula VI, which can be prepared intermediately by photolysis of azidomauric acid esters or by u-elimination with the aid of bases such as triethylamine from N-p-nitro-benzenesulfonyloxyurethanes, react readily with the acrylic acid derivatives used to the desired aziridines of the general formula i< >>(eg Tetrahedron Letters, 1964, 2497; J. Am. chem. soc. 87, 3630 [1965]) .

Ved fremgangsmåte a) kan reaksjonspartnerne omsettes i inerte oppløsningsmidler som f.eks. diethylether, methylenklorid, benzen eller toluen i nærvær av en base. Som baser anvendes fortrinnsvis tertiære aminer som f.eks. triethylamin eller triethanolamin. Like så godt kan man imidlertid arbeide i et tofasesystem som vann/diet hylet her, idet der da fortrinnsvis anvendes uorganiske baser, særlig natriumcarbonat. Som halogenmaursyreestere anvendes som regel klormaursyreesterne. Disse er til dels beskrevet i litteraturen, men ellers kan de.fremstilles ved i og for seg kjente metoder ved omsetning av den tilsvarende alkohol, hhv. fenol, med fosgen i nærvær av en base som pyridin eller N,N-dimethyla nilin. Klormaursyreesterne renses som regel ved destillasjon, men om- In method a), the reaction partners can be reacted in inert solvents such as e.g. diethyl ether, methylene chloride, benzene or toluene in the presence of a base. Tertiary amines are preferably used as bases, such as e.g. triethylamine or triethanolamine. However, it is equally possible to work in a two-phase system such as water/diet here, as inorganic bases are then preferably used, especially sodium carbonate. Chloroformic acid esters are usually used as haloformic acid esters. These are partly described in the literature, but otherwise they can be produced by methods known per se by reacting the corresponding alcohol, or phenol, with phosgene in the presence of a base such as pyridine or N,N-dimethyla niline. The chloroformate esters are usually purified by distillation, but if

settes eventuelt videre også som råprodukt.possibly also passed on as a raw product.

De ved fremgangsmåte b) anvendte dihaldgenforbindelser erThe dihaldene compounds used in method b) are

nye og kan fremstilles ved omsetning av de tilsvarende forbindelser som ikke er halogenert ved .nitrogenatomet, med halogenerings-midler, som f.eks. natriumhypohalogenit eller t-butylhypoklorit. For avspaltning av de to halogenatomer til aziridinderivatet med new and can be produced by reacting the corresponding compounds which are not halogenated at the nitrogen atom with halogenating agents, such as e.g. sodium hypohalite or t-butyl hypochlorite. For splitting off the two halogen atoms of the aziridine derivative with

den generelle formel I kan man anvende vanlige dehalogenerings-midler, fortrinnsvis zink eller natrium. in the general formula I, common dehalogenating agents can be used, preferably zinc or sodium.

De ved fremgangsmåte c) anvendte triazolinderivater er nyeThe triazoline derivatives used in method c) are new

og kan fremstilles ved omsetning av diazoeddiksyrederivater som f.eks. diazoeddiksyreethylester eller diazoacetonitril med methylenurethaner. Nitrogenavspaltningen skjer enten ved belysning i et oppløsningsmiddel som f.eks. diethylether eller aceton, eller katalytisk. Som katalysatorer anvendes edelmetaller eller halv-edelmetaller, fortrinnsvis kobberpulver. and can be produced by reacting diazoacetic acid derivatives such as e.g. diazoacetic acid ethyl ester or diazoacetonitrile with methylene urethanes. The nitrogen removal takes place either by illumination in a solvent such as e.g. diethyl ether or acetone, or catalytic. Precious metals or semi-precious metals, preferably copper powder, are used as catalysts.

For fremstilling av farmasøytiske midler med immunstimulerende virkning blandes forbindelsene med den generelle formel I på i og for seg kjent vis med egnede farmasøytiske bærere, og opparbeides eksempelvis som tabletter eller dragéer, eller suspenderes eller oppløses under tilsetning av tilsvarende hjelpestoffer i vann eller olje, f.eks. olivenolje, og fylles i stikk-kapsler. Da virkestoffet er syrelabilt, forsynes preparatet med et overtrekk som først er oppløselig i det alkaliske tynntarmsmiljø eller blandes med et tilsvarende bærestoff, som f.eks. en høyere fettsyre eller carboxy-methylcellulose. Faste bærestoffer er f.eks. stivelse, lactose, mannit, methylcellulose, talkum, høydisperse kiselsyrer, høyere-molekylære fettsyrer (som stearinsyre), gelatin, agar-agar, calcium-fosfat, magnesiumstearat, animalske og vegetabilske fett og faste høymolekylære polymerer (som polyethylenglycoler), for oral admini-strasjon egnede preparater kan eventuelt smaks- og søtstoffer tilsettes. For the production of pharmaceutical agents with an immunostimulating effect, the compounds of the general formula I are mixed in a manner known per se with suitable pharmaceutical carriers, and processed for example as tablets or dragees, or suspended or dissolved with the addition of corresponding excipients in water or oil, f .ex. olive oil, and filled in pop-up capsules. As the active substance is acid-labile, the preparation is supplied with a coating that is first soluble in the alkaline small intestinal environment or mixed with a corresponding carrier, such as e.g. a higher fatty acid or carboxy-methylcellulose. Solid carriers are e.g. starch, lactose, mannitol, methylcellulose, talc, highly dispersed silicic acids, higher-molecular fatty acids (such as stearic acid), gelatin, agar-agar, calcium phosphate, magnesium stearate, animal and vegetable fats and solid high-molecular polymers (such as polyethylene glycols), for oral administration -stration suitable preparations can optionally have flavorings and sweeteners added.

Som injeksjonsmedium kommer fortrinnsvis vann til anvendelse, som inneholder de for injeksjonsoppløsninger. vanlige tilsetninger som stabiliseringsmidler, oppløsningsformidlere eller svakt As an injection medium, water is preferably used, which contains those for injection solutions. common additives such as stabilizers, solubilizers or weakly

alkaliske puffere. Slike tilsetninger er f.eks. fosfat- eller carbonatpuffere, ethanol, kompleksdannere (som ethylendiamintet ra - eddiksyre og dens ikke-giftige salter), høymolekylære polymerer (som flytende polyethylenoxyd) for viskositetsregulering. alkaline buffers. Such additions are e.g. phosphate or carbonate buffers, ethanol, complexing agents (such as ethylenediaminetetraacetic acid and its non-toxic salts), high molecular weight polymers (such as liquid polyethylene oxide) for viscosity control.

Foretrukket ved foreliggende oppfinnelse er foruten de i de følgende eksempler nevnte forbindelser, også de følgende: 2-cyan-1-aziridin-carboxylsyre-(1-klorethylester) 2-cyan-l-aziridin-carboxylsyre-(1,2-diklorethylester) 2-cyan-l-aziridin-carboxylsyre-(1,2,2,2-tetraklorethylester) 2-cyan-1-aziridin-carboxylsyre-(2-methylfenylester) 2-cyan-1-aziridin-carboxylsyre -(2-methoxyfenylester) 2-cyan-l-aziridin-carboxylsyre-(2-klorf enylest er) 2-cyan-l-aziridin-carboxylsyre-(3-klorfenylester) 2-cyan-l-aziridin-carboxylsyre-(2,4 > 6-tribromfenylester) 2-cyan-l-aziridin-carboxylsyre-(2-nit rof enylester) 2-cyan-l-aziridin-carboxylsyre-(2-aminof enylester) 2-cyan-l-aziridin-carboxylsyre-(3-aminofenylester) 2-cyan-1-aziridin-carboxylsyre-(4-aminof enylest er) 2-cyan-l-aziridin-ca rboxylsyre-(2-hydroxyf enylest er) 2-cyan-l-aziridin-carboxylsyre-(4-hydroxyfenylester) 2-cyan-1-a ziridin-carboxylsyre-(2-t rifluormethylfenylest er) 2-cyan-l-aziridin-ca rboxylsyre-(3-t rifluormethylfenylest er) 2-cyan-l-aziridin-ca rboxylsyre-(4-nitrobenzylest er) 2-cyan-l-aziridin-carboxylsyre-(2-hydroxyet hylest er) 2-cy.an-1-a zir idin-ca rboxylsyre-cyclopropy lest er 2-cyan-1-aziridin-carboxylsyre-(2,2,2-t rifluoret hylest er) 2-cyan-1-aziridin-carboxylsyre-(2-propoxyet hylester) 2-carbamoyl-1-aziridin-carboxylsyré-benzylest er 2-carbamoyl-1-aziridin-carboxylsyre-cyclohexylest er 2-carbamoyl-1-aziridin-carboxylsyre-(4-klorf enylester) 1- ethoxycarbony1-2-aziridin-ca rboxylsyre-isopropylest er 2- ethoxycarbonyl-1-aziridin-carboxylsy re-f enylest er 2-isopropoxycarbonyl-1-aziridin-carboxylsyre-(2,2,2-t riklorethyl- ester) 2-ethoxycarbonyl-1-aziridin-carboxylsyre-allylest ér Preferred in the present invention are, in addition to the compounds mentioned in the following examples, also the following: 2-cyano-1-aziridine-carboxylic acid-(1-chloroethyl ester) 2-cyano-1-aziridine-carboxylic acid-(1,2-dichloroethyl ester) 2-cyano-l-aziridine carboxylic acid-(1,2,2,2-tetrachloroethyl ester) 2-cyano-1-aziridine carboxylic acid-(2-methylphenyl ester) 2-cyano-1-aziridine carboxylic acid -(2-methoxyphenyl ester ) 2-cyano-l-aziridine carboxylic acid-(2-chlorophenyl ester) 2-cyano-l-aziridine carboxylic acid-(3-chlorophenyl ester) 2-cyano-l-aziridine carboxylic acid-(2,4 > 6- tribromophenyl ester) 2-cyano-l-aziridine carboxylic acid-(2-nitrophenyl ester) 2-cyano-l-aziridine carboxylic acid-(2-aminophenyl ester) 2-cyano-l-aziridine carboxylic acid-(3-aminophenyl ester) 2-cyano-1-aziridine carboxylic acid-(4-aminophenyl ester) 2-cyano-l-aziridine carboxylic acid-(2-hydroxyphenyl ester) 2-cyano-l-aziridine carboxylic acid-(4-hydroxyphenyl ester) 2-cyano-1-aziridine-carboxylic acid-(2-trifluoromethylphenyl ester) 2-cyano-1-aziridine-carboxylic acid-(3-trifluoromethylphenyl ester) 2-cyan -1-aziridine-ca rcarboxylic acid-(4-nitrobenzyl ester) 2-cyano-1-aziridine-carboxylic acid-(2-hydroxy ester) 2-cyano-1-a ziridine-ca rcarboxylic acid-cyclopropyl ester 2 -Cyano-1-aziridine-carboxylic acid-(2,2,2-trifluorinated ester) 2-Cyano-1-aziridine-carboxylic acid-(2-propoxyethyl ester) 2-Carbamoyl-1-aziridine-carboxylic acid-benzyl ester 2 -carbamoyl-1-aziridine-carboxylic acid-cyclohexyl ester is 2-carbamoyl-1-aziridine-carboxylic acid-(4-chlorophenyl ester) 1- ethoxycarbonyl-1-2-aziridine-carboxylic acid-isopropyl ester is 2- ethoxycarbonyl-1-aziridine-carboxylic acid -phenylest is 2-isopropoxycarbonyl-1-aziridine-carboxylic acid-(2,2,2-trichloroethyl- ester) 2-ethoxycarbonyl-1-aziridine carboxylic acid allyl ester

De følgende eksempler viser noen av de tallrike fremgangs-måtevarianter som kan anvendes til syntesen av f remga ngsmåt ef or - bindelsene. The following examples show some of the numerous process variants that can be used for the synthesis of process ef or - compounds.

Eksempel 1Example 1

2- cyan-l-a ziridin- carboxylsyre- fenylester2- cyano-l-a ziridine- carboxylic acid- phenyl ester

Til 6,8 g 2-cyanaziridin i 70 ml vann tilsettes ved værelsetemperatur samtidig en oppløsning av 12,6 g klormaursyre-fenylester i 40 ml diethylether og 40 ml 2 N sodaoppløsning. Der omrøres i videre i 2 timer ved værelsetemperatur, fasene skilles, ether-skiktet ekstraheres to ganger med vann, tørres, og den organiske fase inndampes. Residuet omkrystalliseres fra diisopropylether. Utbytte: 10,39(67%). Smp. 60-62°C. To 6.8 g of 2-cyanaziridine in 70 ml of water, a solution of 12.6 g of chloroformic acid phenyl ester in 40 ml of diethyl ether and 40 ml of 2 N soda solution is simultaneously added at room temperature. The mixture is stirred for a further 2 hours at room temperature, the phases are separated, the ether layer is extracted twice with water, dried, and the organic phase is evaporated. The residue is recrystallized from diisopropyl ether. Yield: 10.39(67%). Temp. 60-62°C.

På analogt vis får man ved omsetning av 2-cyanaziridin medAnalogously, one obtains by reacting 2-cyanaziridine with

1. Klormaursyremethylester 2-cyan-1-aziridin-carboxylsyre-methylester 1. Chloroformate methyl ester 2-cyano-1-aziridine carboxylic acid methyl ester

KP0,02: 70 - 72°C KP0.02: 70 - 72°C

2. Klormaursyre-(2,2,2-triklorethylester) 2- cyan- l- aziridin- carboxylsyre-( 2, 2, 2- t riklorethylest er) 2. Chloroformic acid-(2,2,2-trichloroethyl ester) 2-cyano-l-aziridine-carboxylic acid-(2,2,2-trichloroethyl ester)

KpQ 1 : 138 - 139°C Smp.: 86 - 88°C (diisopropylether) KpQ 1 : 138 - 139°C Mp.: 86 - 88°C (diisopropyl ether)

3- Klormaursyre-allylester 3- Chloroformic acid allyl ester

2- cyan- l - a zi r id in- ca rboxy 1 syre- a Hylest er2- cyan- l - azi r id in- ca rboxy 1 acid- a Hylest is

KpQ 2 : 102 - 105°C KpQ 2 : 102 - 105°C

4> Klormaursy re-t -butylester (anvendt som etherisk oppløsning) 4> Chlormaursy re-t-butyl ester (used as ethereal solution)

2- cya n- 1- a ziridin- ca rboxylsyre-t-butylest er2- cyano- 1-a ziridine-ca rboxylic acid-t-butyl ester is

k<p>0,oi: 57 * 59°ck<p>0.oi: 57 * 59°c

5. Klormaursyre-n-pentyleste<r>(Kp100 : 98 - 100°C) 2- cyan- l- aziridin- carboxylsyre-n-pentylest er 5. Chloroformate-n-pentyl ester<r>(Kp100 : 98 - 100°C) 2-cyano-l-aziridine-carboxylic acid-n-pentyl ester is

k<p>0,oi: 93°ck<p>0.0i: 93°c

6.Klormaursyre-cyclohexylester (Kp^: 47°C) 2- cyan- l- azirid in-ca rboxylsyre-cyclohexylest er 6. Chloroformic acid cyclohexyl ester (Kp^: 47°C) 2-cyano-l-aziride in-ca rboxylic acid cyclohexyl ester is

k<p>0,oi: 97°ck<p>0.0i: 97°c

7« Klormaursyre-benzylester 7« Chloroformic acid benzyl ester

2- cyan- 1- aziridin- carboxylsyre-benzylest er2- cyano- 1- aziridine- carboxylic acid benzyl ester

kp0,oi : 145"150°c bp0,oi : 145"150°c

8. Klormaursyre-fenethylester (KP]_g : 120°C) 2- cyan- l- aziridin- carboxylsyre- fenethylest er 8. Chloroformic acid phenethyl ester (KP]_g : 120°C) 2-cyano-l-aziridine-carboxylic acid phenethyl ester is

KP0,oi: 130°c KP0,oi: 130°c

Eksempel 2Example 2

1,2-aziridin-dic arboxylsyre- diethylest er1,2-aziridine-dic carboxylic acid diethyl ester is

Til 2 g 2-aziridin-carboxylsyre-ethylester og 1,79triethylamin 1 20 ml benzen tildryppes ved 0°C en oppløsning av 1,9 g klormaursyre-ethylester i 10 ml benzen, der omrøres så i 2 timer ved værelsetemperatur, ekstraheres tre ganger med vann, benzenfasen tørres i og inndampes. Residuet blir så destillert. To 2 g of 2-aziridine carboxylic acid ethyl ester and 1,79 triethylamine 1 20 ml of benzene is added dropwise at 0°C a solution of 1.9 g of chloroformic acid ethyl ester in 10 ml of benzene, which is then stirred for 2 hours at room temperature, extracted three times with water, the benzene phase is dried and evaporated. The residue is then distilled.

•*Utbytte: 2,0 g (62%). KpQ 2 : 94° C•*Yield: 2.0 g (62%). KpQ 2 : 94°C

Eksempel 3Example 3

2-carbamoyl-1-aziridin- carboxylsyre- feny lester2-carbamoyl-1-aziridine carboxylic acid phenyl ester

Til 2,6 g 2-aziridin-carboxamid i 20 ml vann tildryppes ved 0°C samtidig en oppløsning av 4,79klormaursyre-fenylester i 20 ml diethylether og 30 ml 2 N sodaoppløsning. Omrøringen fortsettes i 10 minutter under isavkjøling, bunnfallet frasuges og vaskes godt med ether. To 2.6 g of 2-aziridine carboxamide in 20 ml of water is simultaneously added dropwise at 0°C a solution of 4.79 chloroformic acid phenyl ester in 20 ml of diethyl ether and 30 ml of 2 N soda solution. Stirring is continued for 10 minutes under ice cooling, the precipitate is suctioned off and washed well with ether.

Utbytte: 4,4 g (71%). Smp.: 140 - l42°C fra toluen.Yield: 4.4 g (71%). M.p.: 140 - 142°C from toluene.

Eksempel 4Example 4

2 - cya n- 1 - a zi r idin- carboxylsy r e- a Hy les ter2 - cyan- 1 - azi ridine- carboxylsy r e- a Hy les ter

Til 2 g 2-cyanaziridin i 20 ml benzen og 39triethylamin tilsettes ved 0°C 3,2 g klormaursyre-allylester i 20 ml benzen. Omrøringen fortsettes i 2 timer ved værelsetemperatur, benzenopp-løsningen ekstraheres to ganger med vann, tørres, og den organiske fase inndampes. Residuet destilleres så. To 2 g of 2-cyanaziridine in 20 ml of benzene and 39triethylamine, 3.2 g of chloroformic acid allyl ester in 20 ml of benzene are added at 0°C. Stirring is continued for 2 hours at room temperature, the benzene solution is extracted twice with water, dried, and the organic phase is evaporated. The residue is then distilled.

Utbytte: 2,9 g (64,5%). KpQ 2 : 102 - 105°CYield: 2.9 g (64.5%). KpQ 2 : 102 - 105°C

På analogt vist får man ved omsetning av 2-cyanaziridin med klormaursyre-ethylest er Analogously, one obtains by reacting 2-cyanaziridine with chloroformic acid ethyl ester

2- cyan- l-azi ridin-ca rboxylsyre-ethylest er2- cyano-l-aziridin-ca rboxylic acid-ethyl ester

Kpo'^o7T~o -75°cKpo'^o7T~o -75°c

Eksempel 5Example 5

2- carbamoyl-1-aziridin-carboxylsyre-ethylest er2- carbamoyl-1-aziridine-carboxylic acid ethyl ester is

Til 2,6 g 2-aziridin-carboxamid i 20 ml vann tildryppes2.6 g of 2-aziridine carboxamide in 20 ml of water is added drop by drop

under isavkjøling samtidig en oppløsning, av 3,25 g klormaursyre- under ice-cooling at the same time a solution of 3.25 g of chloroformate

ethylester i 20 ml diethylether og 15 ml 2 N sodaoppløsning. Reaksjonsblandingen omrøres videre i 1 time under avkjøling, ethyl ester in 20 ml of diethyl ether and 15 ml of 2 N soda solution. The reaction mixture is further stirred for 1 hour while cooling,

skiktene skilles, den vandige fase inndampes, og residuet utkokes med ethanol. Ethanoloppløsningen filtreres, inndampes, og resi- the layers are separated, the aqueous phase is evaporated, and the residue is boiled off with ethanol. The ethanol solution is filtered, evaporated, and resi-

duet omkryst alliseres fra toluen.duet omcross is allized from toluene.

Utbytte: 2,6 g (56%). Smp.: 125 - 128°C.Yield: 2.6 g (56%). Melting point: 125 - 128°C.

På analogt vis får man ved omsetning av 2-aziridin-Analogously, by reacting 2-aziridine-

carboxamid med klormaursyre-methylester carboxamide with chloroformic acid methyl ester

2- carbamoyl- 1- aziridin- carboxylsyre- methylest er2- carbamoyl- 1- aziridine- carboxylic acid- methyl ester

Smp.: 117 - 120°C (fra toluen). 1 Mp.: 117 - 120°C (from toluene). 1

Eksempel 6Example 6

Fremstilling av .2-cyan-1-aziridin-carboxamid fra 2- cyan- 1- aziridin-carboxylsyre-fenylest er Preparation of .2-cyano-1-aziridine-carboxamide from 2-cyano-1-aziridine-carboxylic acid phenyl ester is

1,9 g 2-cyan-1-aziridin-carboxylsyre-fenylester oppløses i1.9 g of 2-cyano-1-aziridine carboxylic acid phenyl ester is dissolved in

30 ml diethylether og tildryppes 20 ml flytende ammoniakk. Der omrøres i 2 timer ved temperaturen for den kokende ammoniakk, opp-løsningen får lov til å anta værelsetemperatur over natten, og det'utfelte 2-cyan-1-aziridin-carboxamid avsuges. 30 ml of diethyl ether and add 20 ml of liquid ammonia drop by drop. The mixture is stirred for 2 hours at the temperature of boiling ammonia, the solution is allowed to reach room temperature overnight, and the precipitated 2-cyano-1-aziridine carboxamide is filtered off with suction.

Utbytte: 0,85 g (77%). Smp.: 74 - 76°C.Yield: 0.85 g (77%). Melting point: 74 - 76°C.

Eksempel 7Example 7

2 - cya n- 1 - a zi r idin- carboxy lsyre- met.hy lest er2 - cyan- 1 - azi ridine- carboxy lsyre- met.hy lest er

Til en oppløsning av 27,5 Q trifenylfosfin, 10,1 g triethylamin og 15,4 g carbontetraklorid i 300 ml methylenklorid tilsettes 14,4 g 2-carbamoyl-1-aziridin-carboxylsyre-methylester, og blandingen kokes under tilbakeløp i 4 timer. Reaksjonsblandingen filtreres, oppløsningen ekstraheres to ganger med vann, den organiske fase tørres og inndampes. Residuet destilleres. To a solution of 27.5 Q of triphenylphosphine, 10.1 g of triethylamine and 15.4 g of carbon tetrachloride in 300 ml of methylene chloride, 14.4 g of 2-carbamoyl-1-aziridine carboxylic acid methyl ester is added, and the mixture is refluxed for 4 hours . The reaction mixture is filtered, the solution is extracted twice with water, the organic phase is dried and evaporated. The residue is distilled.

Utbytte: 3,4 g (27%). KpQ Q2 : 70 - 72°C.Yield: 3.4 g (27%). KpQ Q2 : 70 - 72°C.

Eksempel 8Example 8

2- carbamoyl- l- aziridin- carboxylsyre-ethylest er2- carbamoyl-l-aziridine-carboxylic acid ethyl ester

Til 4,67 g (0,025 mol) 1,2-aziridin-dicarboxylsyre-diethy1-ester i 30 ml ethanol tilsettes den ekvimolare mengde gassformig ammoniakk oppløst i ethanol, og oppløsningen hensettes over natten i kjøleskap. Der inndampes, og den.ønskede 2-carbamoyl-1-aziridin-carboxylsyre-ethylester isoleres ved søylekromatografi (200 g sili-cagel, elueringsmiddel aceton/toluen vplumforhold 1:1). To 4.67 g (0.025 mol) of 1,2-aziridine dicarboxylic acid diethy ester in 30 ml of ethanol is added the equimolar amount of gaseous ammonia dissolved in ethanol, and the solution is left overnight in a refrigerator. It is evaporated, and the desired 2-carbamoyl-1-aziridine-carboxylic acid ethyl ester is isolated by column chromatography (200 g silica gel, eluent acetone/toluene volume ratio 1:1).

Utbytte: 1,4 g (32%). Smp.: 125 - 128°C.Yield: 1.4 g (32%). Melting point: 125 - 128°C.

Eksempel 9Example 9

Fremstilling av 2-cyan-l-aziridin-carboxamid fra 2-cyan-l-azir idin- ca rboxy lsyre- et hy le st er Preparation of 2-cyan-l-aziridine-carboxamide from 2-cyan-l-aziridine-ca rboxylic acid- et hy le st er

4 g 2-cyan-l-aziridin-carboxylsyre-ethylester tilsettes til4 g of 2-cyano-1-aziridine carboxylic acid ethyl ester are added

en oppløsning av 0,79ammoniakkgass i 80 ml vann. Blandingen omrøres ved værelsetemperatur i 4 timer, ekstraheres tre ganger med ethylether, og vannfasen frysetørres så.. Residuet omkrystalliseres fra ethanol under tilsetning av diethylether. a solution of 0.79 ammonia gas in 80 ml of water. The mixture is stirred at room temperature for 4 hours, extracted three times with ethyl ether, and the aqueous phase is then freeze-dried. The residue is recrystallized from ethanol with the addition of diethyl ether.

Utbytte: 1,059(29%). Smp.: 74 - 76°C.Yield: 1.059(29%). Melting point: 74 - 76°C.

Eksempel 10 Example 10

2-cyan-1-a ziri din- carboxylsyre- ethylester2-Cyano-1-aziridin- carboxylic acid ethyl ester

Til 2,11 g 2-(N-carbethoxy-N-klor-amino)-3-klorpropionitril (oljeaktig forbindelse, fremstilt ved omsetning av 2-amino-3~klorpropionitril-hydroklorid (smp. 153 _ 155°C) med klormaursyre-ethylester i nærvær av natriumcarbonat med påfølgende omsetning med t-butylhypoklorit) i 25 ml tethanol tilsettes 0,339aktivert zinkstøv og noe zinkklorid, blandingen omrøres i 12 timer ved værelsetemperatur., avsuges , filtratet inndampes, og residuet destilleres. To 2.11 g of 2-(N-carbethoxy-N-chloro-amino)-3-chloropropionitrile (oily compound, prepared by reacting 2-amino-3-chloropropionitrile hydrochloride (m.p. 153 - 155°C) with chloroformic acid -ethyl ester in the presence of sodium carbonate with subsequent reaction with t-butyl hypochlorite) in 25 ml of ethanol, 0.339 activated zinc dust and some zinc chloride are added, the mixture is stirred for 12 hours at room temperature, filtered off, the filtrate is evaporated, and the residue is distilled.

Utbytte:0,11g (8%). KpQ 01 : 78 - 80°C.Yield: 0.11g (8%). KpQ 01 : 78 - 80°C.

Eksempel 11Example 11

Som beskrevet i eksempel 1, får man ved omsetning av 2-cyan-aziridin med: 1. Klormaursyre-isobutylester 2- cyan- l- aziridin-carboxylsyre-isobut ylest er KpQ 1 : 108 - 110°C 2.Klormaursyre-cyclopropyl-methylester (Kp12: 45 - 46°C) 2- cyan- l- aziridin- carboxylsyre- cyclopropyl- methylest er KpQ)1: 107 - 109°C 3. Klormaursyre-(but-2-enylester) (Kp O , J- 25 - 28°C) 2- cyan- 1- aziridin- carboxylsyre-( but-2-enyl est er) As described in example 1, one obtains by reacting 2-cyano-aziridine with: 1. Chloroformic acid isobutyl ester 2-cyano-l-aziridine carboxylic acid isobutyl ester is KpQ 1 : 108 - 110°C 2. Chloroformic acid cyclopropyl- methyl ester (Kp12: 45 - 46°C) 2- cyano-l-aziridine-carboxylic acid- cyclopropyl- methyl ester is KpQ)1: 107 - 109°C 3. Chloroformate-(but-2-enyl ester) (Kp O , J- 25 - 28°C) 2-cyano-1-aziridine-carboxylic acid-(but-2-enyl ester)

oljeaktig produktoily product

4. Klormaursyre-cyclopentylester (Kp^: 6o -,6l°C) 2- cyan- l- aziridin- carboxylsyre-cyclopentylest er 4. Chloroformic acid cyclopentyl ester (Kp^: 60 -.61°C) 2-cyano-l-aziridine-carboxylic acid cyclopentyl ester is

oljeaktig produktoily product

5. Klormaursyre-bornylester (Kp2: 108 - H0°C) 2- cyan- l- aziridin- carboxylsyre- bornylester 5. Chloroformic acid-bornyl ester (Kp2: 108 - H0°C) 2-cyano-l-aziridine-carboxylic acid-bornyl ester

Kp0)1: 153°C Kp0)1: 153°C

6. Klormaursyre-(2-fluorethylester) (Kp : 110 - 113°C) 2- cyan- l- aziridin- carboxylsyre-( 2- fluorethylester) Kp0)1: 120°C 7. Klormaursyre-(2-klorethylester) (Kp^Q: 83 - 86°C) 2- cyan- 1- aziridin- carboxylsyre-( 2- klorethylest er) oljeaktig produkt 8. Klormaursyre-(2-brometh<y>lest er) 2- cyan- 1- a ziridin- carboxylsyre-( 2- bromethylester) oljeaktig produkt 9 . Klormaursyre-(2-methoxyethylester) 2- cyan- l- aziridin- carboxylsyre-( 2- methoxyethylester) KpQ x : 119-120°C 10. Klormaursyre-tetrahydrofurfurylester (KpQ 2 : 68°C) 2- cyan- 1- aziridin- carboxylsyre- tet rahydrofurf urylester oljeaktig produkt 11. Et hylenglycol-1,2-bis-klormaursyreester (KPg^: H0°C) 1, 2-[ bis-( 2- cyanaziridin- l- ca rbonyloxy)]-etha n oljeaktig produkt 12. Klormaursyre-(2-fenoxyethylester) (KpQ1: 97 - 99°C) 2- cyan- l- a ziridin- carboxylsyre-( 2- f enoxyethylest er) oljeaktig produkt 13. Klormaursyre-(2-fenyl-thioethylester) 2- cyan- 1- aziridin- carboxylsyre-( 2- feny1- thioethylester) oljeaktig produkt 6. Chloroformic acid-(2-fluoroethyl ester) (Kp : 110 - 113°C) 2-cyano-l-aziridine-carboxylic acid-(2-fluoroethyl ester) Kp0)1: 120°C 7. Chloroformic acid-(2-chloroethyl ester) ( Kp^Q: 83 - 86°C) 2-cyano-1-aziridine-carboxylic acid-(2-chloroethyl ester) oily product 8. Chloroformic acid-(2-bromometh<y>lester) 2-cyano-1-a ziridine - carboxylic acid-(2-bromomethyl ester) oily product 9 . Chloroformic acid-(2-methoxyethyl ester) 2-cyano-1-aziridine-carboxylic acid-(2-methoxyethyl ester) KpQ x : 119-120°C 10. Chloroformic acid-tetrahydrofurfuryl ester (KpQ 2 : 68°C) 2-cyano-1-aziridine - carboxylic acid tetrahydrofurfur uryl ester oily product 11. A hylene glycol-1,2-bis-chloroformic acid ester (KPg^: H0°C) 1, 2-[ bis-(2- cyanaziridin-1-ca rbonyloxy)]-etha n oily product 12. Chloroformic acid-(2-phenoxyethyl ester) (KpQ1: 97 - 99°C) 2-cyano-l-aziridine-carboxylic acid-(2-phenoxyethyl ester) oily product 13. Chloroformic acid-(2-phenyl-thioethyl ester) 2-cyano-1-aziridine-carboxylic acid-(2-phenyl-1-thioethyl ester) oily product

14- Klormaursyre-(l-nafthylester) (KpQ ^ : 86 - 90°C) 14- Chloroformate-(l-naphthyl ester) (KpQ ^ : 86 - 90°C)

2- cyan- l- aziridin- carboxylsyre-( 1- naft hylest er) oljeaktig produkt 2-cyano-l-aziridine-carboxylic acid-(1-naphthyl ester) oily product

15-Klormaursyre-(4-methylfenylester) (Kp30<:><10>5 -<106>°<C>) 15-Chloroformic acid-(4-methylphenyl ester) (Kp30<:><10>5 -<106>°<C>)

2- cyan- 1- aziridin- carboxylsyre-( 4- methylfenylester)2- cyano- 1- aziridine- carboxylic acid-(4- methylphenyl ester)

Smp. 88 - 90°C (isopropanol)Temp. 88 - 90°C (isopropanol)

16. Klormaursyre-(2,4-dimethylfenylester) (Kpl2: 100 - 101°C) 2- cyan- 1- aziridin- carboxylsyre-( 2, 4- dimethylfenylester) 16. Chloroformic acid-(2,4-dimethylphenylester) (Kpl2: 100 - 101°C) 2-cyano-1-aziridine-carboxylic acid-(2,4-dimethylphenylester)

Smp. 90 - 91°C (ethanol) • Temp. 90 - 91°C (ethanol) •

17. Klormaursyre-(4-sek-butyl-fenylester) ■ (Kp12 : 122 - 123°C) 2-cy an- 1- aziridin- carboxylsyre-( 4- sek- butyl- fenylester) 17. Chloroformic acid-(4-sec-butyl-phenylester) ■ (Kp12 : 122 - 123°C) 2-cyano-1-aziridine-carboxylic acid-(4-sec-butyl-phenylester)

Smp. 74 - 75°C (ligroin)Temp. 74 - 75°C (Ligroin)

18• Klormaursyre-(4-bifenylest er) 18• Chloroformic acid-(4-biphenyl ester)

2- cyan- 1- aziridin- carboxylsyre-( 4- bifenylester)2- cyano- 1- aziridine- carboxylic acid-( 4- biphenyl ester)

Smp. 107 - 109°C Temp. 107 - 109°C

19. Klormaursyre-( 4-methoxyf enylester) (Kp12: 115 - H7°C) 2- cyan- 1- aziridin- carboxylsyre-( 4- methoxyfenylest er) 19. Chloroformic acid-(4-methoxyphenyl ester) (Kp12: 115 - H7°C) 2-cyano-1-aziridine-carboxylic acid-(4-methoxyphenyl ester)

Smp. 54 - 57°C (diisopropylether)Temp. 54 - 57°C (diisopropyl ether)

20. Klormaursyre-(4-klor-2-methoxyf enylester) (Kp2Q : 138 l40°C) 2-cyan-l-aziridin-carbo xylsyre-( 4- klor- 2- methoxyfenylester) Smp. 114 - H5°C (isopropanol) 21. Klormaursyre-(2-fluorfenylester) (Kp 2 : 68 - 70°C) 2-cyan-l-aziridin-c arboxylsyre-( 2- fluorfenylest er) 20. Chloroformic acid (4-chloro-2-methoxyphenyl ester) (Kp2Q : 138 l40°C) 2-cyano-1-aziridine-carboxylic acid-(4-chloro-2-methoxyphenyl ester) M.p. 114 - H5°C (isopropanol) 21. Chloroformic acid-(2-fluorophenyl ester) (Kp 2 : 68 - 70°C) 2-cyano-l-aziridine-carboxylic acid-(2-fluorophenyl ester)

Smp. 55 - 56°C (isopropanol/vann)Temp. 55 - 56°C (isopropanol/water)

22.Klormaursyre-(4-trifluormethylfenylester) (Kp12: 82 - 84°C) 2- cyan- l- aziridin- carboxylsyre-( 4~ t rifluormethylfenylester) Smp. 75 - 77°C (diisopropylether) 23. Klormaursyre-(4-klorfenylester) (Kp12: 97 - 99°C) 2-cyan-l-azi ridin- ca rboxyls yre-( 4- klorfenylest er) 22.Chloroformic acid-(4-trifluoromethylphenylester) (Kp12: 82 - 84°C) 2-cyano-l-aziridine-carboxylic acid-(4-trifluoromethylphenylester) M.p. 75 - 77°C (diisopropyl ether) 23. Chloroformic acid-(4-chlorophenyl ester) (Kp12: 97 - 99°C) 2-cyan-1-aziridin-carboxylic acid-(4-chlorophenyl ester)

Smp. 79 - 82°C (diisopropylether)Temp. 79 - 82°C (diisopropyl ether)

24. Klormaursyre-(2,4-diklorfenylester) (Kpg : 112 - H7°C) 2- cyan- 1- aziridin-carboxylsyre-( 2, 4- diklorfenylester) 24. Chloroformic acid-(2,4-dichlorophenyl ester) (Kpg : 112 - H7°C) 2-cyano-1-aziridine-carboxylic acid-(2,4- dichlorophenyl ester)

Smp. 82 - 84°CTemp. 82 - 84°C

25. Klormaursyre-(2,4,5-triklorfenylester) (Smp.: 58 - 6o°C) 2- cyan- l- aziridin- carboxylsyre-( 2, 4;5- triklorfenylester) Smp. 100 - 103°C (diisopropylether) 26. Klormaursyre-(4-bromfenylester) (Kp12: 111 - H3°C) 2- cyan- 1- aziridin- carboxylsyre-( 4- bromfenylester) 25. Chloroformic acid-(2,4,5-trichlorophenyl ester) (Mp.: 58 - 6o°C) 2-cyano-l-aziridine-carboxylic acid-(2,4;5-trichlorophenyl ester) M.p. 100 - 103°C (diisopropyl ether) 26. Chloroformic acid-(4-bromophenyl ester) (Kp12: 111 - H3°C) 2-cyano-1-aziridine-carboxylic acid-(4-bromophenyl ester)

Smp. 96 - 100°C (diisopropylether) Temp. 96 - 100°C (diisopropyl ether)

27. Klormaursyre-(3-nitrofenylester) (KpQ ^ •: 120 - 122°C) 2- cyan- l- aziridin- carboxylsyre-( 3- nitrofenylest er) 27. Chloroformic acid-(3-nitrophenyl ester) (KpQ ^ •: 120 - 122°C) 2-cyano-l-aziridine-carboxylic acid-(3-nitrophenyl ester)

Smp. 98 - 100°C (isopropanol)Temp. 98 - 100°C (isopropanol)

28- Klormaursyre-(4-nitrofenylester) 28- Chloroformic acid-(4-nitrophenyl ester)

2- cyan- l- aziridin- carbo xylsyre-( 4- nitrofenylester)2-cyano-l-aziridine-carboxylic acid-(4-nitrophenyl ester)

Smp. 107 -.111°C (diisopropylether)Temp. 107 -.111°C (diisopropyl ether)

29. Klormaursyre-(4-methylthiofenylester) (KpQ 2 : 108°C) 2- cyan- l- aziridin-ca rboxylsyre-( 4- methylthiofenylester) Smp. 73 - 75°C (isopropanol) 30. Klormaursyre-(2-methylsulfonylfenylester) (Smp. 100 - 103°C) 2-cyan-l-azirid in- carboxylsyre-( 2- methylsulfonylf enylest er) Smp. 145 - 150°C (isopropanol) 31. Klormaursyre-(3-formylfenylester) (KpQ ^ : 125°C) 2- cyan- l- aziridin- carboxylsyre-( 3- formylfenylest er) oljeaktig produkt 32. Klormaursyre-(4-acetyl.fenylester) (Kp,- : 121 - 123°C) 29. Chloroformic acid-(4-methylthiophenyl ester) (KpQ 2 : 108°C) 2-cyano-l-aziridine-carboxylic acid-(4-methylthiophenyl ester) M.p. 73 - 75°C (isopropanol) 30. Chloroformic acid-(2-methylsulfonylphenyl ester) (Mp. 100 - 103°C) 2-cyano-l-aziride in- carboxylic acid-(2-methylsulfonylphenyl ester) Mp. 145 - 150°C (isopropanol) 31. Chloroformic acid-(3-formylphenyl ester) (KpQ ^ : 125°C) 2-cyano-l-aziridine-carboxylic acid-(3-formylphenylester) oily product 32. Chloroformic acid-(4- acetyl.phenyl ester) (Kp,- : 121 - 123°C)

2 ->cy an- l- aziridin-car boxylsyre-( 4- acetylfenylester)2 ->cy an- l-aziridine-carboxylic acid-(4- acetylphenyl ester)

Smp. 104 - 107°C Temp. 104 - 107°C

33-Klormaursyre-(4-carbomethoxyfenylester) (Smp.: 47 - 50°C) 33-Chloroformic acid-(4-carbomethoxyphenyl ester) (M.P.: 47 - 50°C)

2- cyan- l- aziridin-carboxylsy re-( 4- carbomethoxyfenylest er) Smp. 86 - 87°C (isopropanol) 2-cyano-1-aziridine-carboxylic acid-(4-carbomethoxyphenyl ester) M.p. 86 - 87°C (isopropanol)

34. Klormaursyre-(4-cyanfenylester) (Kp O j 1: 92- 94°C) 2- cyan- 1- a ziridin- carboxylsyre-( 4-cyan fenylest er) 34. Chloroformic acid-(4-cyanophenyl ester) (Kp O j 1: 92-94°C) 2-cyano-1-aziridine-carboxylic acid-(4-cyanophenyl ester)

Smp. 95 -. 99°C (eddikester/ligroin)Temp. 95 -. 99°C (acetic acid/naphtha)

35.Klormaursyre-(2-fthalimidoethylester) (Smp. 75 - 77°C) 2- cyan- l- aziridin- carboxyisyre-( 2- fthalimidoethylester) Smp. 160 - l63°c (ethanol) 35. Chloroformic acid-(2-phthalimidoethyl ester) (Mp. 75 - 77°C) 2-cyano-l-aziridine-carboxylic acid-(2- phthalimidoethyl ester) M.p. 160 - 163°c (ethanol)

Forbindelser som ble erholdt som "oljeaktig produkt", ble'karakterisert vedNMR- og massespektroskopi. Compounds obtained as "oily product" were characterized by NMR and mass spectroscopy.

Claims (5)

1. Fremgangsmåte ved fremstilling av 1-aziridin-carboxylsyreester-derivater med den generelle formel: 1. Procedure for the preparation of 1-aziridine carboxylic acid ester derivatives with the general formula: hvor X er en nitril-, carbamoyl- eller alkoxycarbonylgruppe, Rer rettkjedet eller forgrenet, mettet eller umettet alkyl som eventuelt er substituert med halogen, alkoxy, amino, carbamoyloxy, cycloalkyl, hydroxy eller imido eller en heterocyclisk gruppe, eller R er cycloalkyl, aryl, aralkyl, aryloxyalkyl eller arylthioalkyl hvor arylgruppen i hvert tilfelle kan være substituert med halogen, alkyl, alkoxy, hydroxy, amino, nitro, cyano, acyl, carbalkoxy, thioalkyl, alkylsulfonyl, fenyl eller trifluormethyl, karakterisert ved at på i og for seg kjent visa) et aziridinderivat med den generelle formel: where X is a nitrile, carbamoyl or alkoxycarbonyl group, Re straight-chain or branched, saturated or unsaturated alkyl which is optionally substituted with halogen, alkoxy, amino, carbamoyloxy, cycloalkyl, hydroxy or imido or a heterocyclic group, or R is cycloalkyl, aryl, aralkyl, aryloxyalkyl or arylthioalkyl where the aryl group can in each case be substituted with halogen, alkyl, alkoxy, hydroxy, amino, nitro, cyano, acyl, carbaloxy, thioalkyl, alkylsulfonyl, phenyl or trifluoromethyl, characterized in that in a manner known per se) an aziridine derivative with the general formula: hvor x er som ovenfor angitt, omsettes med en halogenmaursyreester med den generelle formel: where x is as indicated above, is reacted with a haloformic acid ester of the general formula: hvor R er som ovenfor angitt, og Hal er klor eller brom,.eller b) en forbindelse med den generelle formel: where R is as indicated above, and Hal is chlorine or bromine, or b) a compound with the general formula: hvor X, R og Hal er som ovenfor angitt, behandles med halogen- avspaltende reagenser, ellerc) en forbindelse med den generelle formel: where X, R and Hal are as indicated above, treated with halogen- cleaving reagents, orc) a compound of the general formula: hvor X og R er som ovenfor angitt, ved katalytisk eller fotokjemisk nitrogenavspaltning overføres til en forbindelse med den generelle formel I, og at derpå eventuelt forbindelser med den generelle formel I over-føres til andre forbindelser med den generelle formel I.where X and R are as indicated above, by catalytic or photochemical nitrogen removal is transferred to a compound of the general formula I, and that then possibly compounds with the general formula I are transferred to other compounds with the general formula I. 2. 1-aziridin-carboxylsyreester-derivat er karakterisert ved at de har den generelle formel: 2. 1-aziridine carboxylic acid ester derivative is characterized by having the general formula: hvor X er en nitril-, carbamoyl- eller alkoxycarbonylgruppe, R * er rettkjedet eller forgrenet, mettet eller umettet alkyl som eventuelt kan være substituert med halogen, alkoxy, amino, carbamoyloxy, cycloalkyl, hydroxy eller imido eller en heterocyclisk gruppe, eller R' er cycloalkyl, aryl, aralkyl, aryloxyalkyl eller arylthioalkyl idet arylgruppen i hvert tilfelle eventuelt kan være substituert med halogen, alkyl, alkoxy, hydroxy, amino, nit ro, cyano, acyl, carbalkoxy, thioalkyl, alkylsulfonyl, fenyl eller trifluormethyl, med det forbehold at når x er en nit rilgruppe, kan R' ikke være ethyl.where X is a nitrile, carbamoyl or alkoxycarbonyl group, R * is straight-chain or branched, saturated or unsaturated alkyl which may optionally be substituted with halogen, alkoxy, amino, carbamoyloxy, cycloalkyl, hydroxy or imido or a heterocyclic group, or R' is cycloalkyl, aryl, aralkyl, aryloxyalkyl or arylthioalkyl where the aryl group in each case may optionally be substituted with halogen, alkyl, alkoxy, hydroxy, amino, nitro, cyano, acyl, carbaloxy, thioalkyl, alkylsulfonyl, phenyl or trifluoromethyl, with the proviso that when x is a nitrile group, R' cannot be ethyl. 3. Fremgangsmåte ved fremstilling av 1-aziridin-carboxylsyreester-derivater ifølge krav 2, karakterisert ved at nitrener med den generelle formel : 3. Process for the production of 1-aziridine carboxylic acid ester derivatives according to claim 2, characterized in that nitrenes with the general formula: hvor R' er som ovenfor angitt, omsettes med en forbindelse med den generelle formel: where R' is as indicated above, is reacted with a compound of the general formula: hvor X er som ovenfor angitt.where X is as indicated above. 4» Anvendelse av forbindelser med den generelle formel I, hvor X er en nitrilgruppe, som utgangsmateriale ved fremstilling av 2-cyan-l-aziridin-carboxamid.4» Use of compounds of the general formula I, where X is a nitrile group, as starting material in the preparation of 2-cyano-1-aziridine carboxamide. 5. Anvendelse av forbindelser med den generelle formel I, hvor X er carbamoyl eller alkoxycarbonyl, som utgangsmateriale ved fremstilling av forbindelser med den generelle formel I, hvor X er en nitrilgruppe.5. Use of compounds of the general formula I, where X is carbamoyl or alkoxycarbonyl, as starting material in the preparation of compounds of the general formula I, where X is a nitrile group.
NO774225A 1976-12-11 1977-12-09 PROCEDURE FOR THE PREPARATION OF 1-AZIRIDINE-CARBOXYLIC ACID RESIDUES NO774225L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762656323 DE2656323A1 (en) 1976-12-11 1976-12-11 Immunostimulant aziridine carboxylic acid derivs. - with substits. in 2-position
DE19772740248 DE2740248A1 (en) 1977-09-07 1977-09-07 Immunostimulant aziridine carboxylic acid derivs. - with substits. in 2-position

Publications (1)

Publication Number Publication Date
NO774225L true NO774225L (en) 1978-06-13

Family

ID=25771246

Family Applications (1)

Application Number Title Priority Date Filing Date
NO774225A NO774225L (en) 1976-12-11 1977-12-09 PROCEDURE FOR THE PREPARATION OF 1-AZIRIDINE-CARBOXYLIC ACID RESIDUES

Country Status (23)

Country Link
JP (1) JPS5373555A (en)
AR (1) AR218645A1 (en)
AT (1) AT361496B (en)
AU (1) AU3137877A (en)
CH (1) CH637116A5 (en)
CS (1) CS198277B2 (en)
DD (1) DD132659A5 (en)
DK (1) DK550377A (en)
ES (1) ES464855A1 (en)
FI (1) FI773711A7 (en)
FR (1) FR2373528A1 (en)
GB (1) GB1559916A (en)
IL (1) IL53549A (en)
IT (1) IT1089634B (en)
LU (1) LU78659A1 (en)
NL (1) NL7713460A (en)
NO (1) NO774225L (en)
NZ (1) NZ185901A (en)
OA (1) OA05817A (en)
PL (1) PL202798A1 (en)
PT (1) PT67378B (en)
SE (1) SE7713876L (en)
SU (1) SU751322A3 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2833986A1 (en) * 1978-08-03 1980-02-21 Boehringer Mannheim Gmbh IMMUNITIMULATING N-SUBSTITUTED AZIRIDINE-2-CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
JPS62111909A (en) * 1985-11-09 1987-05-22 Shiseido Co Ltd Nail beautifying cosmetic
US6476236B1 (en) * 2001-11-26 2002-11-05 The Arizona Board Of Regents Synthesis of 2-cyanoaziridine-1-carboxamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE110492C (en) *

Also Published As

Publication number Publication date
SU751322A3 (en) 1980-07-23
AT361496B (en) 1981-03-10
CH637116A5 (en) 1983-07-15
DD132659A5 (en) 1978-10-18
FR2373528A1 (en) 1978-07-07
ES464855A1 (en) 1978-08-01
IT1089634B (en) 1985-06-18
AU3137877A (en) 1979-06-14
PT67378B (en) 1979-05-18
AR218645A1 (en) 1980-06-30
LU78659A1 (en) 1979-02-02
CS198277B2 (en) 1980-05-30
PT67378A (en) 1978-01-01
IL53549A (en) 1981-11-30
GB1559916A (en) 1980-01-30
OA05817A (en) 1981-05-31
NZ185901A (en) 1979-06-08
ATA882877A (en) 1980-08-15
JPS5373555A (en) 1978-06-30
SE7713876L (en) 1978-06-12
IL53549A0 (en) 1978-03-10
DK550377A (en) 1978-06-12
NL7713460A (en) 1978-06-13
FR2373528B1 (en) 1981-11-13
FI773711A7 (en) 1978-06-12
PL202798A1 (en) 1979-06-04

Similar Documents

Publication Publication Date Title
WO1998009949A1 (en) Novel acetamide derivatives and protease inhibitors
CN100402496C (en) Compounds useful as matrix metalloproteinase inhibitors
FI59991B (en) PROCEDURE FOR THE FRAMSTATION OF AV 2-ARYLAMINO-2-IMIDAZOLINE DERIVATIVES AND DERAS SALTER
US6372933B1 (en) Process for preparing certain phenyl urea compounds
CN112272665B (en) Method for preparing lifalast
NO774225L (en) PROCEDURE FOR THE PREPARATION OF 1-AZIRIDINE-CARBOXYLIC ACID RESIDUES
KR101881918B1 (en) New process for the synthesis of acylsulfonamides derivatives
US4376731A (en) 1-Aziridine carboxylic acid derivatives with immunostimulant activity
US3978126A (en) N-hydroxy-amidine compounds
US4203904A (en) Alkylation of aniline with a lactone in the presence of a base
JPS63203672A (en) Novel heterocyclic compound
SU1121261A1 (en) Process for preparing heterylthiocarboxylic acid arylamides
SU489319A3 (en) The method of obtaining coumarin derivatives
JPS6360969A (en) Production of imidazole derivative
CA2268544A1 (en) N.alpha.-2-(4-nitrophenylsulfonyl)ethoxycarbonyl-amino acids
JP2671401B2 (en) .ALPHA.-Aminothioacetamide derivative and its production method
US5672711A (en) Process for manufacturing cephem derivatives
JPS6124379B2 (en)
HU201516B (en) Process for producing 2-cyano-2-oximinoacetamide derivatives
JP4302974B2 (en) Method for producing oxazole compound
Li et al. Asymmetric synthesis and absolute stereochemistry of 4, 4-bis-(trifluoromethyl) imidazoline based ACAT inhibitors
KR800001142B1 (en) Process for 1-aziridine-carboxylic ester derivatives
EP0082523A2 (en) Intermediates for the preparation of 4-phenyl-1,3-benzodiazepins and methods for preparing the intermediates
KR100665761B1 (en) Hydroxamic Acid and Carboxylic Acid Derivatives
RU1794941C (en) N-(3-nitro-4-chlorophenylsulfonyl)-5-chloroanthranilic acid as an intermediate for synthesis of n-(4-chlorophenyl)-2-(3-nitro-4-chlorophenylsulfonyl)amino-5- chlorobenzamide showing antitrichocephaliasis activity